Vnitr Lek 2024, 70(5):E27

Výsledky léčby hypertenze v České republice v letech 1972-2022

Arian Taniwall1, Jan Brož2, Michala Lustigová3, 4, Lucia Fačkovcová2, Jana Urbanová1
1 Interní klinika FNKV a 3. LF UK, Praha
2 Interní klinika FN Motol a 2. LF UK, Praha
3 Státní zdravotní ústav, Praha
4 PřF UK, Praha

Published: September 4, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Taniwall A, Brož J, Lustigová M, Fačkovcová L, Urbanová J. Výsledky léčby hypertenze v České republice v letech 1972-2022. Vnitr Lek. 2024;70(5):E27.
Download citation

References

  1. Taniwall A, Broz J, Lustigova M, et al. Effectiveness of treatment of arterial hypertension in Central Europe from 1972 to 2022. Bratisl Lek Listy. 2024;125(5):322-330. doi: 10.4149/BLL_2024_48. Go to original source... Go to PubMed...
  2. Widimský J. 50 let historie léčby hypertenze. Triton, 2001:62-84.
  3. Cífková R, Škodová Z, Bruthans J, et al. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Čas Lék Čes. 2004;143:219-225.
  4. Cífková R, Bruthans J, Wohlfahrt P, et al. The prevalence of major cardiovascular risk factors in the Czech population in 2015-2018. The Czech post-MONICA study. Cor Vasa. 2020;62(1):6-16. doi: 10.33678/cor.2020.010. Go to original source...
  5. Cífková R, Bruthans J, Strilchuk L, et al. Longitudinal trends in blood pressure, prevalence, awareness, treatment, and control of hypertension in the Czech population. Are there any sex differences? Front Cardiovasc Med. 2022 Nov 10;9:1033606. doi: 10.3389/fcvm.2022.1033606. Go to original source... Go to PubMed...
  6. Jozífová M, Cífková R, Škodová Z, et al. A comparison of hypertension control and the risk profile of hypertensives in the general population and in a specialist centre. Cor Vasa. 2003;44(11):533-41.
  7. Souček M, Widimský J, Žižka J, et al. Treatment of hypertension in an internist's office. Interní Medicína pro praxi. 2010;12(11):561-564.
  8. Vejtasová V, Lustigová M, Urbanová J, et al. Prevalence and management of arterial hypertension in the population aged 25-64 in the Czech Republic with a focus on diabetic patients. Epidemiol. Mikrobiol. Imunol. 2021;70(4):247-252.
  9. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021 Sep 11;398(10304):957-980. doi: 10.1016/S0140-6736(21)01330-1. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.